Haleon plc (NYSE:HLN – Get Free Report)’s share price gapped down before the market opened on Friday . The stock had previously closed at $9.57, but opened at $9.37. Haleon shares last traded at $9.38, with a volume of 726,683 shares.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $10.95.
Get Our Latest Stock Analysis on HLN
Haleon Stock Performance
Haleon (NYSE:HLN – Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.62 billion for the quarter, compared to the consensus estimate of $3.74 billion. During the same period last year, the company earned $0.10 earnings per share. On average, research analysts anticipate that Haleon plc will post 0.43 EPS for the current year.
Institutional Trading of Haleon
Institutional investors and hedge funds have recently bought and sold shares of the stock. Nicholas Hoffman & Company LLC. bought a new stake in shares of Haleon during the 4th quarter worth approximately $146,000. Sierra Ocean LLC acquired a new position in Haleon during the fourth quarter worth $26,000. Allworth Financial LP raised its position in Haleon by 31.8% during the fourth quarter. Allworth Financial LP now owns 9,884 shares of the company’s stock worth $90,000 after acquiring an additional 2,383 shares in the last quarter. Strategic Financial Concepts LLC acquired a new stake in Haleon in the fourth quarter valued at $847,000. Finally, Principal Securities Inc. grew its position in shares of Haleon by 46.4% in the 4th quarter. Principal Securities Inc. now owns 78,878 shares of the company’s stock valued at $752,000 after acquiring an additional 24,997 shares during the period. Institutional investors own 6.67% of the company’s stock.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Read More
- Five stocks we like better than Haleon
- Canadian Penny Stocks: Can They Make You Rich?
- Nebius Group: Market Overreaction or Real AI Disruption?
- 3 Small Caps With Big Return Potential
- The Best Way to Invest in Gold Is…
- Top Biotech Stocks: Exploring Innovation Opportunities
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.